AQR Capital Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
AQR Capital Management's VCYT Position: Q2 2026 in Review
AQR Capital Management increased its Veracyte (VCYT) stake by 66% in Q2 2026, buying an estimated $2.49M and bringing the position to 149,648 shares worth $8.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1651.
AQR Capital Management first reported a position in VCYT in Q1 2019 and has held it in 27 quarters since. The position peaked at $11.7M in Q2 2019. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- AQR Capital Management held 149,648 shares of Veracyte worth $8.79M as of Q2 2026.
- AQR Capital Management bought 59,326 Veracyte shares in Q2 2026, an estimated $2.49M.
- Veracyte made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #1651 holding.
- AQR Capital Management first reported a position in Veracyte in Q1 2019 and has held it in 27 quarters since.
- AQR Capital Management's Veracyte position peaked at $11.7M in Q2 2019.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.